Corrigendum

The following accepted article from the Journal of Neurochemistry entitled, ‘CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats’ by Hu et al. (2015), erratically published an incorrect number of animals (n) used for the CXCL12 2 μg control group shown in Figures 1b and 1f. To clarify, six (n = 6) instead of five animals were used. Figures  1a, 1e, 2b, 2c, 2d and 2e also used six animals (n = 6) for the CXCL12 2 μg control group. The corresponding author confirms that the figure panels 1a/b, 1e/f, 2b/d and 2c/e, respectively, include the same cohort of control animals (see filled red circles representing the CXCL12 2 μg control group in the figures below).